InsidersTradesSigma
Track the TARSUS PHARMACEUTICALS INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was disclosed on 4 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BOBAK AZAMIAN. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
TARSUS PHARMACEUTICALS INC es una empresa farmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades oculares. Cotiza en NASDAQ bajo el ticker TARS.